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Pyrrole and 2-azetidinone are two essential heterocyclic scaffolds, which are being broadly used in
medicinal chemistry and drug discovery field. A green and practical method to synthesize novel N-(2-
azetidinonyl) 2,5-disubstituted pyrroles, which are comprised of both pyrrole and 2-azetidinone moieties,
has been developed. The classical Paal–Knorr reaction is one of the simplest and most economical methods
for the synthesis of biologically important and pharmacologically useful pyrrole derivatives. The present
procedure for the synthesis of N-(2-azetidinonyl) 2,5-disubstituted pyrroles (1,2,5-trisubstituted pyrroles)
has been accomplished by reacting 3-amino b-lactams and 2,5-hexanedione in the presence of bismuth
nitrate pentahydrate as an ecofriendly catalyst using microwave irradiation under solvent free condition. A
comparison has also been made between the efficiency of microwave-assisted condition and the classical
method (stirring at room temperature). The present method is equally effective for N-polyaromatic
substituted b-lactams and optically pure b-lactams with chemically sensitive functionalities. The structure
and stereochemistry of the products have been confirmed by extensive spectroscopic and X-ray
crystallographic analyses. The present procedure for synthesizing N-(2-azetidinonyl) 2,5-disubstituted
pyrroles may find application in the development of potent pharmacologically active molecules.
Introduction
Nitrogen heterocycles are pervasive in drug development
research, among which pyrrole and 2-azetidinone (b-lactam)
are two most important pharmacophores, often found in
synthetic and natural drugs.1 They possess a central place
among various classes of pharmacophores due to their diverse
and interesting medicinal properties. However, more than 70
years of extensive, and sometimes unnecessary, use of
b-lactams has enabled bacteria to develop a broad range of
resistance mechanisms. The development of multidrug resis-
tance has reduced the effectiveness of b-lactams as antimicro-
bial drugs.2 The main reason for b-lactam resistance is the
production of b-lactamase; consequently, the development of
b-lactamase inhibitors has been one of the main strategies in
drug development. Nonetheless, the versatility of the b-lactam
core structure, combined with the innovation of medicinal
chemists, has repeatedly led to the development of new
generations of b-lactam antibiotics that are capable of
overcoming the problems caused by mounting bacterial
resistance. Other than anti-infective properties b-lactam
derivatives have also demonstrated a wide range pharmacolo-
gical activity which includes antidiabetic, anti-inflammatory,
antiparkinsonian, anti-HIV as well as anticancer.1–6
On the other hand, pyrrole-derived alkaloids along with
lamellarins are a large family of marine alkaloids with novel
structures and promising bioactivities.7 A variety of naturally
occurring 3,4- or 2,5- di- or 1,2,5-trisubstituted pyrroles have
been isolated from ascidians, mollusks, sponges and cucum-
bers. Many of these highly complex pyrroles have been found
to exhibit bioactivity.8,9 The pharmacological activity of 1-(2-
hydroxy-3-dimethylaminopropyl)-2,5-dimethylpyrrole was also
reported.10 Based upon these encouraging results, the synth-
esis of novel N-(2-azetidinonyl)-2,5-disubstituted pyrroles was
undertaken. We report herein the green synthesis of a variety
of 1,2,5-trisubstituted pyrroles having 2-azetidinone scaffold
on pyrrole nitrogen. These structurally unique molecules may
reveal potential application in future drug discovery research.
Results and discussion
The continuing drive for practically simple and efficient
organic transformations has resulted in the development of
many novel concepts and methodologies. Of particular
importance is the field of environmentally benign reactions.
Over the past decade, protection of the environment and waste
prevention has been increasingly emphasized by researchers
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from both academia and industry.11 For this reason the
elimination or reduction of volatile solvents in organic
synthesis is an important goal. These types of processes can
contribute significantly in green chemistry. In this context
development of solvent-free synthetic methods or the replace-
ment of hazardous solvents with environmentally benign
solvents has become an important and popular research topic
in recent years.12,13
Our laboratory has been performing the microwave-
induced reactions for many years. We have successfully
developed several new reaction methodologies using micro-
wave irradiation technique. Some recent examples include
stereoselective synthesis of b-lactams,14–16 synthesis of pyr-
roles,17–20 aza-Michael addition,21 and synthesis of quinox-
alines22. On the other hand organo-bismuth chemistry23–26 is
considered as a promising field of research in synthetic
organic chemistry. Bismuth nitrate pentahydrate, a solid salt is
commercially available from a number of companies around
the world, very economical and nontoxic compared to other
Lewis acids. We have demonstrated the catalytic activity of
trivalent bismuth nitrate pentahydrate in a number of
examples. These investigations resulted in various novel
methods that include nitration of aromatic systems,27–29
Michael reaction,30 protection of carbonyl compounds,31
deprotection of oximes and hydrazones,32 Paal–Knorr synth-
esis of pyrroles,33 hydrolysis of amide,34 electrophilic substitu-
tion of indoles,35,36 synthesis of a-aminophosphonates,37 and
Hantzsch 1,4-dihydropyridines38. Our success in the bismuth
nitrate-induced reaction has revealed that this reagent acts as
a Lewis acid type of activator. It has been conceived by our
group that N-(2-azetidinonyl) 2,5-dimethyl pyrroles can be
easily prepared using bismuth nitrate as the catalyst.
Moreover, it has been found that this reagent is compatible
in the presence of acid-sensitive functionalities like primary
amine and four-membered cyclic amide (b-lactam moiety).
This idea has been extended in this paper to react 2,5-
hexanedione with 3-amino substituted 2-azetidinones in the
presence of catalytic amount of bismuth nitrate under solvent-
free condition.
In another note, the anticancer activity of the marketed
drugs often results in a number of undesired side effects as
well as multidrug resistance (MDR). Therefore, it has become
essential to develop new anticancer agents with less side
effects, minimum toxicity, superior pharmacological proper-
ties, and improved overall activity against diverse classes of
tumors. As a part of our ongoing research, we have been
engaged for the synthesis of new anticancer agents with
special emphasis on b-lactam anticancer for the past several
years.39–45 We have also developed new methodologies for the
synthesis of anticancer pyrroles.33,39 During the course of
investigation on Paal–Knorr synthesis of pyrroles, we envisage
that 1,2,5-trisubstituted pyrroles, where position 1 (nitrogen) is
substituted by b-lactam moiety can be synthesized by reacting
3-amino b-lactams and 2, 5-hexanedione as the staring
materials in the presence of an acidic catalyst following
Paal–Knorr method.46,47 The 3-amino b-lactams are easily
prepared from 3-phthalimido b-lactams which are synthesized
through Staudinger cycloaddition48 reaction of imines and
acid chloride (equivalent) following Scheme 1.
Reaction of C,N-diaryl imines 1 with N-phthaloylglycine in
the presence of triethylamine and 2-chloro-
N-methylpyridinium iodide was performed at 0 uC–room
temperature and a mixture of (¡)-cis and (¡)-trans b-lactams
was isolated. However, polyaromatic imines 1 derived from
6-chrysenyl amine produced exclusively (¡)-trans b-lactams.
High temperature reaction also gave an identical result in
comparable yield. The reaction proceeded well with diverse
imines that have different types of aromatic groups (Scheme 1)
in good to excellent yield of the products. At the beginning of
our approach, to synthesize N-(2-azetidinonyl) 2,5-dimethyl
pyrroles from 3-amino substituted b-lactams the reaction
between 1 mmol of (¡)-trans-3-amino-1,4-diphenylazetidin-2-
one (3a) with 1.1 mmol of 2,5-hexanedione was used as a
model study. Our initial study started with screening of
catalyst loading to obtain optimal reaction conditions for the
synthesis of N-(2-azetidinonyl) 2,5-disubstituted pyrroles. A
number of bismuth salts e.g. bismuth chloride, bismuth
bromide bismuth iodide, bismuth triflate, bismuth subnitrate,
and bismuth nitrate pentahydrate were screened using 1
mmol of 3a with 1.1 mmol of 2,5-hexanedione as the
substrates under automated CEM microwave irradiation (260
Watts, 80 uC, 20–45 psi, 1 min). The results are shown in
Scheme 1 Synthesis of 3-amino 2-azetidinones.
Table 1 Microwave-assisted (260 Watts, 80 uC, 20–45 psi) synthesis of N-(2-
azetidinonyl) 2,5-disubstituted pyrrole from 1 mmol of (¡)-trans-3-amino-1,4-
diphenylazetidin-2-one with 1.1 mmol of 2,5-hexanedione using bismuth-salts
as catalyst (10 mol%) under solventless condition (1 min): catalyst optimization
Entry Bi-salt (10 mol %) Yield (%)a
1 BiCl3 56
2 BiBr3 51
3 BiI3 40
4 Bi(OTf)3 57
5 Bi5O(OH)9(NO3)3 36
6 Bi(NO3)3?5H2O 91
7 No catalyst 16
a isolated yield.
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Table 1. It has also been discovered that the reaction gives
products with extreme rapidity under microwave irradiation.
Bismuth nitrate pentahydrate was found to be the best
catalyst among other bismuth salts under this condition (Entry
6, Table 1). Without using any catalyst (only microwave
irradiation) 16% yield of the product was isolated after five
minutes irradiation (Entry 7, Table 1). The same probe was
used to optimize the amount of the catalyst bismuth nitrate
pentahydrate (Table 2). The results show that 5 mol% bismuth
nitrate pentahydrate was required to complete the reaction
within a minute (Entry 6, Table 2).
It is very convenient to conduct the reaction with bismuth
nitrate because of its stability in the presence of moisture and
oxygen. The presence of small amounts of catalyst (5 mol%) is
necessary for the success of the reaction. The reaction was
then performed in various solvents as well as in neat condition
under an identical microwave power using bismuth nitrate
pentahydrate (5 mol%) as the catalyst to identify the best
solvent/condition (Table 3). From these studies, it was
confirmed that bismuth nitrate pentahydrate is the best
catalyst, among all other Lewis acids investigated for this
reaction, under neat condition (Entry 8, Table 3).
After determining the optimized condition we carried out a
series of reaction (Scheme 2) using 3-amino b-lactams (1
mmol) with 2,5-hexanedione (1.1 mmol) in the presence of
bismuth nitrate pentahydrate (5 mol%) under microwave
irradiation (260 Watts, 80 uC, 20–45 psi). The 3-amino
substituted b-lactams were synthesized following the proce-
dure developed in our laboratory.49,50
The reaction proceeded equally well irrespective of the
nature of substituent present in the b-lactam ring without any
change of stereochemistry. A series of diversely
C,N-disubstituted 3-amino b-lactams yielded the correspond-
ing N-(2-azetidinoyl)-2,5-dimethyl pyrroles following Scheme 2.
Upon extraction of the reaction mixture excellent yield of the
corresponding pyrroles were obtained (Table 4). The model
reaction was also conducted following classical condition,
stirring a mixture of (¡)-trans-3-amino-1,4-diphenylazetidin-2-
one (1 mmol), 2,5-hexanedione (1.1 mmol) and bismuth
nitrate (5 mol%) at room temperature, under solventless
condition. The reaction yielded only 48% corresponding
pyrrole even after 36 h. Next, the model reaction was
conducted following the same classical condition in presence
Table 2 Microwave-assisted (260 Watts, 80 uC, 20–45 psi) synthesis of N-(2-
azetidinonyl) 2,5-disubstituted pyrrole from 1 mmol of (¡)-trans-3-amino-1,4-
diphenylazetidin-2-one with 1.1 mmol of 2,5-hexanedione using bismuth
nitrate pentahydrate as catalyst under solventless condition (1 min): optimiza-
tion of the amount of the catalyst
Entry Bi(NO3)3?5H2O (mol%) Yield (%)
a
1 30 73
2 25 71
3 20 83
4 15 87
5 10 91
6 5 96
7 2 63
8 1 39
a isolated yield.
Table 3 Microwave-assisted (260 Watts, 80 uC, 20–45 psi) synthesis of N-(2-
azetidinonyl) 2,5-disubstituted pyrrole from 1 mmol of (¡)-trans-3-amino-1,4-
diphenylazetidin-2-one with 1.1 mmol of 2,5-hexanedione using bismuth
nitrate pentahydrate as catalyst (5 mol%) for 1 min: solvent optimization
Entry Solvent (1 mL) Yield (%)a
1 Toluene 32
2 Dichloromethane 27
3 Tetrahydrofuran 78
4 Methanol 80
5 Ethanol 77
6 Dimethylsulfoxide 72
7 Water 81
8 Neat 96
a isolated yield.
Scheme 2 Stereoselective synthesis of N-(2-azetidinoyl)-2,5-dimethyl pyrroles.
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of 0.5 mL water which yields the corresponding pyrrole in 61%
yield after 16 h. The same set of reactions (Table 4) were
performed under classical condition by stirring a mixture of
3-amino b-lactam (1 mmol), 2,5-hexanedione (1.1 mmol) and
bismuth nitrate (5 mol%) at room temperature in water (0.5
mL) and the results are summarized in Table 4.
The formation of a mixture of isomeric products in case of
monoaryl imines had cast doubt about the analysis of the
product distributions of earlier studies.51,52 The present study
confirmed the formation of two isomeric cis and trans
products. Previous studies on the same reaction reported the
formation of trans isomer only with imines that have
monoaromatic groups at the C- and N-terminus. It appears
that the electron withdrawing aromatic groups at the C- and
N-terminus of the imine is responsible for the formation of the
trans isomer. The effect of electron withdrawing property is
highly significant when chrysenyl group is present at the
N-terminus of the imine. In case of N-chrysenyl imines only
the trans isomer was isolated as the sole product. The
formation of trans isomer in case of N-chrysenyl imines and
N-monoaryl imines can be rationalized through an isomeriza-
tion of the enolate as described earlier.42–44 Polyaromatic
group (in this example, chrysenyl) on the nitrogen stabilizes
the iminium ion greatly. The electron withdrawing property of
monocyclic aromatic groups at the N-site of the imine is not
sufficient to have a complete isomerization of the enolate and
therefore, a mixture of cis- and trans-isomers is formed. The
stereochemistries of the corresponding cis and trans N-(2-
azetidinonyl) 2,5-dimethyl pyrroles (4b and 4b9) have been
confirmed by X-ray crystallographic analysis (Fig. 1 and 2).53,54
As mentioned earlier, the trans N-(2-azetidinonyl) 2,5-
dimethyl pyrrole was isolated as the sole product for
N-chrysenyl imine 1, retaining the stereochemistry of the
corresponding phthalimido b-lactams. No change in stereo-
Table 4 Bismuth nitrate-induced synthesis of N-(2-azetidinonyl) 2,5-dimethyl pyrroles from 3-amino substituted b-lactams under solventless condition
Entry
Substrate
(3-amino b-lactam)
Product [N-(2-azetidinonyl)-2,
5-dimethyl pyrrole]
Condition A: Stirring at
room temperature
Condition B: MWI
(260 Watts, 80 uC, 20–45 psi)
Time (h) Yield (%)a Time (min) Yield (%)a
1 3a 4a 16 58 1 90
2b 3a9 4a9 16 61 1 96
3 3b 4b 16 66 1 98
4b 3b9 4b9 16 59 1 92
5 3c 4c 24 49 5 91
6 3d 4d 24 52 5 87
7 3e 4e 24 57 4 94
8 3f 4f 24 47 3 88
9 3g 4g 24 44 5 87
10 5a 6a 16 67 1 89
11 5b 6b 16 64 1 94
a isolated yield. b cis stereochemistry.
Fig. 1 X-ray crystallographic (ORTEP) structure of (4b). Thermal ellipsoids are
shown with 50% probability.
Fig. 2 X-ray crystallographic (ORTEP) structure of (4b9). Thermal ellipsoids are
shown with 50% probability.
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chemistry was observed in this reaction. The trans stereo-
chemistry of one the polyaromatic imine derived trans N-(2-
azetidinonyl) 2,5-dimethyl pyrrole (4e) has been confirmed by
X-ray crystallographic analysis (Fig. 3).55 The sulfur atom of the
thiophenyl moiety (S1A–B) and the carbon atom (C25A–B) are
disordered. Both the sulfur atom and the carbon atom occupy
50% of the time flipping back and forth from each position.
Probably because of extremely high rate of flipping the
subsequent flippomers are not visible individually in NMR
time scale and only one set of values was observed.56 This
observation is highly interesting because this is the first
example of a molecule, having b-lactam core, exists in
flippomer forms.
The mechanism of the reaction has not been studied in
detail. A plausible mechanistic pathway involves the nucleo-
philic attack of the electron pair on nitrogen attached to C-3 of
the 2-azetidinone ring system to one of the carbonyl groups of
2,5-hexanedione under the influence of bismuth nitrate
pentahydrate. The process is highly accelerated under micro-
wave irradiation. A second nucleophilic attack to the other
carbonyl group and subsequent dehydration-aromatization
yields N-(2-azetidinonyl) 2,5-dimethyl pyrrole as the sole
product (Scheme 3). This reaction suggests the capability of
bismuth nitrate to serve as a Lewis activator.
The effectiveness of our newly developed methodology was
further tested for the synthesis of optically pure N-(2-
azetidinoyl)-2,5-dimethyl pyrroles. To achieved this goal,
3-Phthalimido substituted 2-azetidinones were synthesized
from optically pure 2,2-dimethyl-1,3-dioxolane-4-carboxalde-
hyde following a published method.57 The 3-phthalimido
substituted b-lactams were deprotected by ethylene diamine as
reported from our laboratory.50 The corresponding 3-amino
substituted b-lactams (5) produced 3-pyrrole substituted
b-lactams (6) upon treatment with 2,5-hexanedione in the
presence of 5 mol% of bismuth nitrate pentahydrate at room
temperature as well as under microwave-induced procedure
(Scheme 4) as discussed herein. Synthetic method for the
preparation of optically pure N-(2-azetidinoyl)-2,5-dimethyl
pyrroles is still unknown despite gigantic development in this
field in the past several decades. Because of the mild
conditions of the experiments, it is gratifying to note that no
deprotection of the acid-sensitive ketal group to diol and
subsequent oxidation, rearrangement and lactonization was
occurred in the synthesis of pyrroles (6) (Scheme 4). The
bismuth nitrate-catalyzed pyrrole formation reaction of
3-amino b-lactams as described herein is very simple and
can be used with remarkable success.
Conclusion
Among the wide variety of heterocycles, which have been
explored for developing pharmaceutically significant mole-
cules, 2-azetidinones and pyrroles are noteworthy. The
discovery, development and identification of pharmacologi-
Fig. 3 X-ray crystallographic (ORTEP) structure of (4e) acetone solvate. Thermal
ellipsoids are shown with 50% probability.
Scheme 3 Plausible mechanism for the synthesis of N-(2-azetidinonyl) 2,5-
dimethyl pyrroles.
Scheme 4 Synthesis of optically pure N-(2-azetidinoyl)-2,5-dimethyl pyrroles.
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cally active compounds has gained immense importance in
the present era. Because of the interest of b-lactams and
pyrroles in organic and medicinal chemistry, research in this
field continues to produce new and appealing innovations.
The discovery and development of commercially viable orally
active b-lactam antibiotics and inhibitors of Class A and C
b-lactamases remain as significant challenges for medicinal
chemists. The production, under environmentally benign
conditions, of more efficient and cost-effective medicines is
one of most exciting dreams of industrial medicinal chemistry.
The present economical method satisfies most of the
principles of green chemistry and the unique structures of
the N-(2-azetidinoyl)-2,5-dimethyl pyrroles reported in this
paper may provide important new leads for the discovery of
drugs for many dreadful diseases with novel mechanisms of
action.
Experimental
General
Melting points were determined in a Fisher Scientific electro-
chemical Mel-Temp* manual melting point apparatus (Model
1001) equipped with a 300 uC thermometer. FT-IR spectra were
recorded on a Bruker Alpha modular Platinum-ATR FT-IR
spectrometer with OPUS software, using the samples directly
(neat) without making pallets. 1H-NMR (600 MHz) and 13C-
NMR (150 MHz) spectra were obtained at room temperature
with Bruker superconducting UltrashieldTM Plus 600 MHz
NMR spectrometer with central field 14.09 Tesla, coil
inductance 89.1 Henry and magnetic energy 1127.2 kJ using
CDCl3 as solvent. Elemental analyses (C, H, N) were conducted
using the Perkin-Elmer 2400 series II elemental analyzer, their
results were found to be in good agreement (¡0.2%) with the
calculated values for C, H, N. Bismuth nitrate pentahydrate
(reagent grade) 98% (Cat # 248592-500G, Batch # MKBC6772)
purchased from Sigma-Aldrich Corporation was used. All other
chemicals were purchased from Sigma-Aldrich Corporation
(analytical grade). Throughout the project solvents were
purchased from Fisher-Scientific. Deionized water was used
for the preparation of all aqueous solutions.
General procedure for the synthesis of N-(2-azetidinonyl)-2,5-
dimethyl pyrrole from 3-amino substituted b-lactam
The substrate (3-amino substituted b-lactam, 1.0 mmol), 2,5-
hexanedione (1.1 mmol) and bismuth nitrate pentahydrate (5
mol%, 24 mg) were mixed together in a microwave vial with a
magnetic stir bar. The mixture was irradiated in an automated
microwave (CEM Corporation) and the progress of the reaction
was monitored by TLC. After completion of the reaction
(Table 4) dichloromethane (7 mL) was added to the reaction
mixture and the organic layer was washed with saturated
sodium bicarbonate solution, brine and water successively. It
was dried over anhydrous sodium sulfate and the solvent was
removed under reduced pressure. The crude mass was purified
through a small silica gel column using ethyl acetate/hexanes
as eluent. The spectral and analytical data are as follow:
(¡)-Trans-3-(2,5-dimethyl-1H-pyrrol-1-yl)-1,4-diphenylazeti-
din-2-one (4a): Yellowish crystals (90%, 284 mg, dichloro-
methane/hexanes); mp 149–150 uC; IR (neat) 2966 (Ar CH),
1751 (lactam CO), 1598 and 1499 (Ar CLC), 1370 (CH3), 1228
(C—N), 768 and 745 (mono-substituted benzene) cm21; 1H-
NMR (600 MHz, CDCl3) d 2.13 (6H, s, pyrroyl C(2,5) CH3), 5.07
(1H, d, J = 2.34 Hz, C(4)H), 5.19 (1H, d, J = 2.46 Hz, C(3)H), 5.84
(2H, s, pyrroyl C(3,4)H), 7.13–7.44 (10H, m, phenyl H); 13C-
NMR (150 MHz, CDCl3) d 12.98, 64.02, 70.15, 107.48, 117.50,
124.70, 125.72, 128.60, 129.00, 129.36, 129.41, 135.99, 137.04,
163.63. Anal. Calcd for C21H20N2O: C, C, 79.72; H, 6.37; N, 8.85.
Found: C, 79.87; H, 6.29; N, 8.88.
(¡)-Trans-3-(2,5-dimethyl-1H-pyrrol-1-yl)-1-(4-methoxyphe-
nyl)-4-phenylazetidin-2-one (4b): white crystals (98%, 339 mg,
dichloromethane/hexanes); mp 164–165 uC; IR (neat) 2926 (Ar
CH), 1759 (lactam CO), 1548 and 1508 (Ar CLC), 1381 (CH3),
1292, 1239 (C—N), 838 (para-substituted benzene) cm21; 1H-
NMR (600 MHz, CDCl3) d 2.02 (6H, s, pyrroyl C(2,5) CH3), 3.67
(3H, s, OCH3), 4.91 (1H, d, J = 2.10 Hz, C(4)H), 5.05 (1H, d, J =
2.28 Hz, C(3)H), 5.72 (2H, s, pyrroyl C(3,4)H), 6.74 (2H, d, J =
6.84 Hz, C(2,6) p-methoxyphenyl H), 7.18–7.31 (7H, m, C(3,5)
p-methoxyphenyl and phenyl H); 13C-NMR (150 MHz, CDCl3) d
12.96, 55.47, 64.11, 70.12, 107.41, 114.55, 118.85, 125.77,
128.59, 128.96, 129.42, 130.52, 136.05, 156.63, 162.98. Anal.
Calcd for C22H22N2O2: C, 76.28; H, 6.40; N, 8.09. Found: C,
76.22; H, 6.37; N, 8.02.
(¡)-Trans-1-(chrysen-6-yl)-3-(2,5-dimethyl-1H-pyrrol-1-yl)-4-
phenylazetidin-2-one (4c): yellow crystals (91%, 424 mg,
dichloromethane/diethyl ether/hexanes); mp 111–113 uC; IR
(neat) 2959 (Ar CH), 1767 (lactam CO), 1593 (Ar CLC), 1386
(CH3), 1303, 1239 (C—N), 820, 756, 699 (meta-substituted
benzene) cm21; 1H-NMR (600 MHz, CDCl3) d 2.19 (6H, s,
pyrroyl C(2,5) CH3), 5.37 (1H, d, J = 2.58 Hz, C(4)H), 5.60 (1H,
d, J = 2.58 Hz, C(3)H), 5.81 (2H, s, pyrroyl C(3,4)H), 7.15–7.26
(5H, m, phenyl H), 7.54–7.62 (2H, m, chrysenyl H), 7.70–7.71
(2H, m, chrysenyl H), 7.88–7.90 (2H, m, chrysenyl H), 8.40–8.42
(1H, m, chrysenyl H), 8.43 (1H, s, chrysenyl C(5)H), 8.48 (1H, d,
J = 8.34 Hz, chrysenyl H), 8.57 (1H, d, J = 9.12 Hz, chrysenyl H),
8.72–8.74 (1H, m, chrysenyl H); 13C-NMR (150 MHz, CDCl3) d
13.31, 65.70, 68.43, 107.65, 114.02, 120.92, 122.81, 123.67,
124.55, 125.97, 126.79, 126.84, 126.90, 126.95, 127.54, 127.56,
127.76, 128.66, 128.71, 128.99, 129.30, 129.99, 131.41, 131.68,
132.28, 135.85, 164.95. Anal. Calcd for C33H26N2O: C, 84.95; H,
5.62; N, 6.00. Found: C, 84.83; H, 5.51; N, 5.93.
(¡)-Trans-1-(chrysen-6-yl)-3-(2,5-dimethyl-1H-pyrrol-1-yl)-4-
(4-methoxyphenyl)azetidin-2-one (4d): yellowish red amor-
phous solid (87%, 431 mg, dichloromethane/diethyl ether/
hexanes); mp 142 uC; IR (neat) 2951 (Ar CH), 1758 (lactam CO),
1611, 1592, 1516, (Ar CLC), 1388 (CH3), 1301, 1244, 1173 (C—
N), 822 (para-substituted benzene), 754 (meta-substituted
benzene) cm21; 1H-NMR (600 MHz, CDCl3) d 2.20 (6H, s,
pyrroyl C(2,5) CH3), 3.59 (3H, s, OCH3), 5.36 (1H, d, J = 2.64 Hz,
C(4)H), 5.54 (1H, d, J = 2.64 Hz, C(3)H), 5.80 (2H, s, pyrroyl
C(3,4)H), 6.70 (2H, d, J = 8.88 Hz, para-methoxyphenyl
C(2,6)H), 7.28 (2H, d, J = 8.82 Hz, para-methoxyphenyl
C(3,5)H), 7.55–7.90 (6H, m, chrysenyl H), 8.38–8.40 (1H, m,
chrysenyl H), 8.42 (1H, s, chrysenyl C(5) H), 8.49 (1H, d, J = 8.28
Hz, chrysenyl H), 8.56 (1H, d, J = 9.06 Hz, chrysenyl H), 8.71–
8.73 (1H, m, chrysenyl H); 13C-NMR (150 MHz, CDCl3) d 13.32,
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55.19, 65.55, 68.47, 107.54, 114.29, 114.70, 120.92, 122.83,
123.66, 124.49, 126.77, 126.89, 126.90, 127.42, 127.48, 127.55,
127.58, 127.72, 128.66, 128.70, 160.07, 165.09. Anal. Calcd for
C34H28N2O2: C, 82.23; H, 5.68; N, 5.64. Found: C, 82.07; H,
5.62; N, 5.56.
(¡)-Trans-1-(chrysen-6-yl)-3-(2,5-dimethyl-1H-pyrrol-1-yl)-4-
(thiophen-2-yl)azetidin-2-one (4e): Light yellow (almost color-
less) crystal (94%, 443 mg, dichloromethane/diethyl ether/
hexanes); mp 231 uC; IR (neat) 3102, 2970 (Ar CH), 1765
(lactam CO), 1510, 1588 (Ar CLC), 1388 (CH3), 1301, 1237 (C—
N), 822, 757, 701 (meta-substituted benzene) cm21; 1H-NMR
(600 MHz, CDCl3) d 2.26 (6H, s, pyrroyl C(2,5) CH3), 5.56 (1H,
d, J = 2.52 Hz, C(4)H), 5.82 (2H, s, pyrroyl C(3,4)H), 5.84 (1H, d,
J = 2.52 Hz, C(3)H), 6.77 (1H, dd, J = 4.98 Hz and 3.60 Hz,
thiophenyl C(3)H), 7.04 (1H, dd, J = 4.50 Hz and 0.84 Hz,
thiophenyl C(4)H), 7.11 (1H, dd, J = 5.94 Hz and 0.96 Hz,
thiophenyl C(5)H), 7.57–7.92 (4H, m, chrysenyl H), 8.29–8.30
(2H, m, chrysenyl H), 8.47 (1H, s, chrysenyl C(5) H), 8.52–8.73
(4H, m, chrysenyl H); 13C-NMR (150 MHz, CDCl3) d 13.32,
62.19, 69.31, 107.73, 115.36, 120.92, 122.84, 123.65, 124.31,
126.36, 126.82, 126.97, 126.98, 127.11, 127.29, 127.42, 127.53,
127.82, 127.96, 128.71, 128.73, 130.06, 130.73, 131.62, 132.27,
139.06, 164.73. Anal. Calcd for C31H24N2OS: C, 78.78; H, 5.12;
N, 5.93. Found: C, 78.89; H, 5.02; N, 5.87.
(¡)-Trans-1-(chrysen-6-yl)-3-(2,5-dimethyl-1H-pyrrol-1-yl)-4-
(ferrocenyl)azetidin-2-one (4f): Orange crystal (88%, 505 mg,
dichloromethane/diethyl ether); mp 244–246 uC; IR (neat)
2953, 2926 (Ar CH), 1728 (lactam CO), 1597, 1574 (Ar CLC),
1381 (CH3), 1273 (C—N), 822, 738, 699 (meta-substituted
benzene) cm21; 1H-NMR (600 MHz, CDCl3) d 2.39 (6H, s,
pyrroyl C(2,5) CH3), 3.68 (5H, s, ferrocenyl C(19, 29, 39, 49, 59)H,
3.99 (1H, m, ferrocenyl H), 4.01 (1H, m, ferrocenyl H), 4.06
(1H, m, ferrocenyl H), 4.08 (1H, m, ferrocenyl H), 5.38 (1H, d, J
= 2.58 Hz, C(4)H), 5.49 (1H, d, J = 2.58 Hz, C(3)H), 5.84 (2H, s,
pyrroyl C(3,4)H), 7.58–7.96 (6H, m, chrysenyl H), 8.22 (1H, m,
chrysenyl H), 8.57 (1H, s, chrysenyl H), 8.59–8.78 (3H, m,
chrysenyl H); 13C-NMR (150 MHz, CDCl3) d 13.50, 63.52, 65.97,
66.95, 67.04, 68.67, 68.71, 68.76, 68.88, 83.62, 107.77, 116.61,
120.99, 122.81, 123.79, 124.27, 126.87, 127.05, 127.09, 127.53,
127.57, 127.88, 127.98, 128.08, 128.56, 128.80, 130.09, 131.25,
131.63, 132.35, 165.56. Anal. Calcd for C37H30FeN2O: C, 77.35;
H, 5.26; N, 4.88. Found: C, 78.23; H, 5.17; N, 4.79.
(¡)-Trans-1-(chrysen-6-yl)-3-(2,5-dimethyl-1H-pyrrol-1-yl)-4-
(furan-2-yl)azetidin-2-one (4g): Yellow crystal (87%, 396 mg,
dichloromethane/diethyl ether/hexanes); mp 135–137 uC; IR:
2912 (Ar CH), 1753 (lactam CO), 1581, 1560 (Ar CLC), 1377
(CH3), 1310 (C–N), 782 (meta-substituted benzene) cm
21; 1H-
NMR d (ppm): 1H-NMR (600 MHz, CDCl3) d 2.30 (6H, s, pyrroyl
C(2,5) CH3), 5.47 (1H, d, J = 2.46 Hz, C(4)H), 5.65 (1H, d, J =
2.46 Hz, C(3)H), 5.91 (2H, s, pyrroyl C(3,4)H), 6.77 (2H, m, furyl
H), 7.35–8.59 (12H, m, Ar–H); 13C-NMR d (ppm): 13.45, 65.63,
68.55, 107.65, 114.41, 114.77, 122.98, 123.77, 124.56,
126.86,127.00, 127.55, 127.81, 128.78, 129.07, 129.38, 129.97,
135.98, 141.05, 160.14, 165.23. Anal. Calcd for C31H24N2O2: C,
81.56; H, 5.30; N, 6.14. Experimental: C, 81.58; H, 5.29; N, 6.08.
(¡)-Cis-3-(2,5-dimethyl-1H-pyrrol-1-yl)-1,4-diphenylazetidin-
2-one (4a9): Deep brown amorphous solid (96%, 303 mg,
dichloromethane/hexanes); mp 136–137 uC; IR (neat) 2958 (Ar
CH), 1720 (lactam CO), 1603 and 1460 (Ar CLC), 1384 (CH3),
1278 (C—N), 742 and 697 (mono-substituted benzene) cm21;
1H-NMR (600 MHz, CDCl3) d 2.09 (6H, s, pyrroyl C(2,5) CH3),
5.21 (1H, d, J = 5.49 Hz, C(4)H), 5.32 (1H, d, J = 5.49 Hz, C(3)H),
7.03 (2H, m, pyrroyl C(3,4)H), 7.27–7.81 (10H, m, phenyl H);
13C-NMR (150 MHz, CDCl3) d 14.12, 61.27, 68.18, 107.99,
117.65, 124.52, 125.95, 126.16, 128.81, 129.03, 129.14, 129.17,
135.84, 137.16, 162.05. Anal. Calcd for C21H20N2O: C, 79.72; H,
6.37; N, 8.85. Found: C, 79.69; H, 6.31; N, 8.89.
(¡)-Cis-3-(2,5-dimethyl-1H-pyrrol-1-yl)-1-(4-methoxyphenyl)-
4-phenylazetidin-2-one (4b9): white crystals (92%, 318 mg,
dichloromethane/hexanes); mp 147–148 uC; IR (neat) 2922 (Ar
CH), 1739 (lactam CO), 1546 and 1512 (Ar CLC), 1396 (CH3),
1239 and 1173 (C—N), 819 (para-substituted benzene) cm21;
1H-NMR (600 MHz, CDCl3) d 2.11 (6H, br s, pyrroyl C(2,5) CH3),
3.72 (3H, s, OCH3), 5.34 (1H, d, J = 5.58 Hz, C(4)H), 5.67 (1H, d,
J = 5.58 Hz, C(3)H), 6.80 (2H, d, J = 9.06 Hz, C(2,6)
p-methoxyphenyl H), 6.95 (2H, d, J = 7.02 Hz, pyrroyl
C(3,4)H), 7.09–7.37 (7H, m, C(3,5) p-methoxyphenyl and
phenyl H); 13C-NMR (150 MHz, CDCl3) d 13.64, 55.54, 61.43,
64.83, 107.04, 114.54, 118.59, 126.57, 128.09, 128.28, 131.40,
132.66, 136.46, 156.64, 162.37. Anal. Calcd for C22H22N2O2: C,
76.28; H, 6.40; N, 8.09. Found: C, 76.31; H, 6.33; N, 8.00.
(3R,4R)-4-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(2,5-dimethyl-
1H-pyrrol-1-yl)-1-phenylazetidin-2-one (6a): Yellow amorphous
solid (89%, 302 mg, dichloromethane/hexanes); mp 122–124
uC; IR (neat) 2958, 2930 (Ar CH), 1759 (lactam CO), 1602 and
1495 (Ar CLC), 1370 (CH3), 1291, 1212 (C—N), 712 and 699
(mono-substituted benzene) cm21; 1H-NMR (600 MHz, CDCl3)
d 1.39 (3H, s, dioxolane CH3), 1.39 (3H, s, dioxolane CH3), 2.12
(3H, s, pyrroyl CH3), 2.31 (3H, s, pyrroyl CH3), 2.91 (1H, dd, J =
7.53 Hz and 2.46 Hz, dioxolane C(5)H), 3.16 (1H, dd, J = 8.30
Hz and 0.54 Hz, dioxolane C(5)H), 4.30 (1H, dd, J = 5.70 Hz and
3.12 Hz, C(4)H), 5.42 (1H, d, J = 5.70 Hz, C(3)H), 5.74 (1H, ddd,
J = 14.46 Hz, 3.33 Hz and 0.60 Hz, dioxolane C(4)H), 7.09–7.74
(7H, m, Ar H); 13C-NMR (150 MHz, CDCl3) d 14.05, 14.39,
25.54, 26.57, 62.95, 65.78, 68.18, 76.34, 107.77, 109.15, 118.22,
124.86, 130.88, 132.48, 137.82, 163.15. Anal. Calcd for
C20H24N2O3: C, 70.56; H, 7.11; N, 8.23. Found: C, 70.48; H,
6.99; N, 8.16.
(3R,4R)-4-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(2,5-dimethyl-
1H-pyrrol-1-yl)-1-(4-methoxyphenyl)azetidin-2-one (6b): Pale
yellow amorphous solid (94%, 347 mg, dichloromethane/
hexanes); mp 130–132 uC; IR (neat) 2967 (Ar CH), 1753 (lactam
CO), 1572 and 1516 (Ar CLC), 1398 (CH3), 1291, 1254 (C—N),
832 (para-substituted benzene) cm21; 1H-NMR (600 MHz,
CDCl3) d 1.26 (3H, s, dioxolane CH3), 1.35 (3H, s, dioxolane
CH3), 2.18 (3H, s, pyrroyl CH3), 2.38 (3H, s, pyrroyl CH3), 2.98
(1H, dd, J = 7.71 Hz and 2.46 Hz, dioxolane C(5)H), 3.23 (1H, t,
J = 8.58 Hz, dioxolane C(5)H), 3.81 (3H, s, OCH3), 3.86 (1H, dd,
J = 8.34 Hz and 2.40 Hz, C(4)H), 5.49 (1H, d, J = 5.58 Hz, C(3)H),
5.77 (2H, s, pyrroyl H), 5.84 (1H, dd, J = 14.79 Hz, 2.82 Hz,
dioxolane C(4)H), 6.90 (2H, d, J = 9.06 Hz, C(2,6) p-methox-
yphenyl H), 7.85 (2H, d, J = 8.92 Hz, C(3,5) p-methoxyphenyl
H); 13C-NMR (150 MHz, CDCl3) d 14.03, 14.31, 25.55, 26.55,
55.47, 63.05, 65.75, 68.13, 76.30, 105.81, 107.67, 114.09,
119.63, 123.41, 134.18, 156.72, 162.57. Anal. Calcd for
C21H26N2O4: C, 68.09; H, 7.07; N, 7.56. Found: C, 67.96; H,
7.00; N, 7.47.
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53 All reflection intensities were measured at 110(2) K using a
KM4/Xcalibur (detector: Sapphire3) with enhance graphite-
monochromated Mo-Ka radiation (l = 0.71073 Å) under the
program CrysAlisPro (Version 1.171.36.20, Agilent
Technologies, 2012). The program CrysAlisPro (Version
1.171.36.20, Agilent Technologies, 2012) was used to refine
the cell dimensions. Data reduction was done using the
program CrysAlisPro (Version 1.171.36.20, Agilent
Technologies, 2012). The structure was solved with the
program SHELXS-97 (Sheldrick, 2008) and was refined on
F2 with SHELXL-97 (Sheldrick, 2008). Analytical numeric
absorption corrections based on a multifaceted crystal
model were applied using CrysAlisPro (Version 1.171.36.20,
Agilent Technologies, 2012). The temperature of the data
collection was controlled using the system Cryojet (man-
ufactured by Oxford Instruments). The H atoms were
placed at calculated positions using the instruction AFIX
13, AFIX 43 or AFIX 137 with isotropic displacement
parameters having values 1.2 or 1.5 times Ueq of the
attached C atoms. Fw = 346.42, colorless lath, 0.34 6 0.14
6 0.08 mm3, orthorhombic, Pbcn (no. 60), a = 31.2908(12),
b = 9.2585(3), c = 12.6610(5) Å, V = 3668.0(2) Å 3, Z = 8, Dc =
1.255 g cm23, m = 0.081 mm21, abs. corr. range: 0.990–
0.998. 8916 Reflections were measured up to a resolution of
(sin h/l)max = 0.57 Å
21. 2867 Reflections were unique (Rint =
0.0505), of which 2068 were observed [I . 2s(I)]. 238
Parameters were refined. R1/wR2 [I . 2s(I)]: 0.0434/0.0870.
R1/wR2 [all refl.]: 0.0730/0.0960. S = 1.015. Residual
electron density found between 20.18 and 0.17 e Å23.
Crystallographic data for (¡)-Cis-3-(2,5-dimethyl-1H-pyrrol-
1-yl)-1-(4-methoxyphenyl)-4-phenylazetidin-2-one have
been deposited as DBTX-312 (Cis) with the Cambridge
Crystallographic Data Centre as CCDC 932934. Copies of
the data can be obtained, free of charge, on application to
CCDC, 12 Union Road, Cambridge CB2 IEZ, UK (fax: +44
1223 336033 or e-mail: deposit@ccdc.cam.ac.uk).
54 All reflection intensities were measured at 100(2) K using a
SuperNova diffractometer (equipped with Atlas detector)
with Cu-Ka radiation (mirror optics, l = 1.54178 Å) under
the program CrysAlisPro (Version 1.171.36.24 Agilent
Technologies, 2012). The program CrysAlisPro (Version
1.171.36.24 Agilent Technologies, 2012) was used to refine
the cell dimensions. Data reduction was done using the
program CrysAlisPro (Version 1.171.36.24 Agilent
Technologies, 2012). The structure was solved with the
program SHELXS-97 (Sheldrick, 2008) and was refined on
F2 with SHELXL-97 (Sheldrick, 2008). Analytical numeric
absorption corrections based on a multifaceted crystal
model were applied using CrysAlisPro (Version 1.171.36.24
Agilent Technologies, 2012). The temperature of the data
collection was controlled using the system Cryojet (man-
ufactured by Oxford Instruments). The H atoms were
placed at calculated positions using the instructions AFIX
13, AFIX 43 or AFIX 137 with isotropic displacement
parameters having values 1.2 or 1.5 times Ueq of the
attached C atoms. Fw = 346.42, very thin colorless lath, 0.49
6 0.17 6 0.03 mm3, monoclinic, P21/n (no. 14), a =
9.5368(2), b = 11.2841(3), c = 16.5037(5) Å, b = 90.689(2)u, V
= 1775.90(8) Å3, Z = 4, Dc = 1.296 g cm
23, m = 0.664 mm21,
abs. corr. range: 0.830–0.981. 18253 Reflections were
measured up to a resolution of (sin h/l)max = 0.59 Å
21.
3194 Reflections were unique (Rint = 0.0284), of which 3004
were observed [I . 2s(I)]. 238 Parameters were refined. R1/
wR2 [I . 2s(I)]: 0.0392/0.0941. R1/wR2 [all refl.]: 0.0415/
0.0957. S = 1.067. Residual electron density found between
20.20 and 0.21 e Å23. Crystallographic data for (¡)-Trans-
3-(2,5-dimethyl-1H-pyrrol-1-yl)-1-(4-methoxyphenyl)-4-phe-
nylazetidin-2-one (4a) have been deposited as DBTX-312
(Trans) with the Cambridge Crystallographic Data Centre
as CCDC 932935. Copies of the data can be obtained, free
of charge, on application to CCDC, 12 Union Road,
Cambridge CB2 IEZ, UK (fax: +44 1223 336033 or e-mail:
deposit@ccdc.cam.ac.uk).
55 X-ray crystallographic data were recorded with an auto-
matic single crystal X-ray diffractometer consists of a 3 kw
X-ray generator, Saturn 724 CCD detector, AFC12K goni-
ometer, and X-stream 2000 (for nitrogen generation). The
compound crystallizes in the P21/n space group with only
one molecule in the asymmetric unit, situated on a general
position. All non-hydrogen atoms were refined anisotropi-
cally. Hydrogen atoms were placed on calculated positions
and were refined with Uiso(H) = 1.2–1.5 Ueq (C). The title
compound (20 mg) was added to 10 mL of acetone then
methylene chloride was added drop wise until the
compound dissolved. Suitable X-ray quality crystals were
formed from slow evaporation of the solvent. An X-ray
quality colorless platelet crystal (crystal system: mono-
clinic) was selected for structural analysis. In regards to the
thiophene ring, there is only one sulfur atom but this
sulfur atom flips back and forth between two positions
hence there is one sulfur atom located 50% of the time at
each position. Crystallographic data for (¡) Trans-N-
(chrysen-6-yl)-3-(2,5-dimethyl-1H-pyrrol-1-yl)-4-(thiophen-2-
yl)azetidin-2-one acetone solvate have been deposited as
tcdptaa with the Cambridge Crystallographic Data Centre
as CCDC 933213. Copies of the data can be obtained, free
of charge, on application to CCDC, 12 Union Road,
Cambridge CB2 IEZ, UK (fax: +44 1223 336033 or
e-mail:deposit@ccdc.cam.ac.uk).
56 A. Banerji, D. Bandyopadhyay, P. Sengupta, B. Basak,
T. Prange´ and A. Neuman, Tetrahedron Lett., 2006, 47,
3827–3830.
57 A. K. Bose, B. K. Banik, C. Mathur, D. R. Wagle and M.
S. Manhas, Tetrahedron, 2000, 56, 5603–5619.
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